(Q30422068)

16 October 2017

A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients (English)

1 reference

16 October 2017

0 references

placebo-controlled trial

1 reference

8

1 reference

16 October 2017

Maryam Afshar

13

0 references

Robert L Stout

object named as

Robert Stout

17

0 references

Helen Marie Pettinati

11

object named as

Helen Pettinati

1 reference

16 October 2017

Raye Z Litten

1

1 reference

16 October 2017

Joanne B Fertig

2

1 reference

16 October 2017

Daniel E Falk

3

1 reference

16 October 2017

Megan L Ryan

4

1 reference

16 October 2017

Margaret E Mattson

5

1 reference

16 October 2017

Joseph F Collins

6

1 reference

16 October 2017

Cristin Murtaugh

7

1 reference

16 October 2017

Alan I Green

9

1 reference

16 October 2017

Bankole Johnson

10

1 reference

16 October 2017

Robert Swift

12

1 reference

16 October 2017

Mary F Brunette

14

1 reference

16 October 2017

Nassima A-D Tiouririne

15

1 reference

16 October 2017

Kyle Kampman

16

1 reference

16 October 2017

NCIG 001 Study Group

18

1 reference

16 October 2017

26 September 2011

1 reference

Alcoholism: Clinical and Experimental Research

16 October 2017

1 reference

16 October 2017

36

1 reference

16 October 2017

3

1 reference

16 October 2017

406-416

1 reference

The efficacy of disulfiram for the treatment of alcohol use disorder.

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Alcohol-use disorders in the critically ill patient

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Alcohol biomarkers in applied settings: recent advances and future research opportunities

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

A role for brain stress systems in addiction

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Effects of aripiprazole on subjective and physiological responses to alcohol

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Topiramate for treating alcohol dependence: a randomized controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Is alcohol assessment therapeutic? Pretreatment change in drinking among alcohol-dependent women

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Development of medications for alcohol use disorders: recent advances and ongoing challenges

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Potential benefits of quetiapine in the treatment of substance dependence disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Quetiapine for treatment of alcohol dependence.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Placebo response in studies of major depression: variable, substantial, and growing

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

A rating scale for extrapyramidal side effects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Quantification of Sleepiness: A New Approach

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Addictive behaviors: etiology and treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

A rating scale for drug-induced akathisia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Calculating standard drink units: international comparisons.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Techniques to enhance compliance with disulfiram

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Allocation of Patients to Treatment in Clinical Trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

A New Depression Scale Designed to be Sensitive to Change

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence

20 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

Psychometric properties of the Penn Alcohol Craving Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01649.X

Signal detection and placebo response in schizophrenia: parallels with depression.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Ethyl glucuronide in hair compared with traditional alcohol biomarkers--a pilot study of heavy drinkers referred to an alcohol detoxification unit

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

The effect of olanzapine on craving and alcohol consumption

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Ensuring balanced distribution of prognostic factors in treatment outcome research.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248956

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21950727

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reliability of a family tree questionnaire for assessing family history of alcohol problems

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21950727

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1530-0277.2011.01649.X

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

21950727

1 reference